glp 1 nafld Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) Pharmacotherapy for Non-alcoholic Fatty Liver

The high cost of GLP-1 plus the risk of inappropriate or unnecessary prescriptions requires GLP-1 coverage to be a structured process with checks and balances to ensure necessary and effective prescribing and avoid side effects that can result in early discontinuation

Some patients find success with over-the-counter antacids or H2 blockers like famotidine, though proton pump inhibitors (PPIs) may be necessary if symptoms persist beyond 4 weeks

28 Treatment with IV fluid supplementation should continue as appropriate based on patient factors until the anion gap closes and acidosis has resolved

Yoshida, N

GHRP-2 Best for: Powerful GH stimulation, serious recovery needs GHRP-2 is a first-generation growth hormone-releasing peptide that produces some of the strongest GH pulses among the GHRP class